Music Therapy for Severe Dementia
(AMUSED Trial)
Trial Summary
What is the purpose of this trial?
The goal of this pilot randomized clinical trial is to learn if a music therapy treatment, called AMUSED, can improve engagement and reduce behavioral symptoms in older adults with severe dementia who live in care facilities. The main questions it aims to answer are: * Is it feasible to conduct a full-scale trial of AMUSED? * Can investigators identify the best outcome measures to assess impact on behavioral symptoms of dementia? * Does speech offer a useful indicator of treatment effectiveness? Researchers will compare a group-based music therapy treatment to a reading activity to learn if music therapy leads to greater improvements in behavioral symptoms and speech patterns. Participants will: * Participate in either music therapy (includes live music, singing, and rhythmic instrument playing) or a reading group with stories about life and nature and talk about memories. * Attend small group sessions twice a week for 12 weeks, with each session lasting 40 minutes between lunch and dinner. * Be observed and assessed for behavioral symptoms, cognition, and speech several times during treatment and at a 4-week follow-up.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications. It is best to consult with the trial coordinators or your healthcare provider for guidance.
What data supports the effectiveness of the treatment AMUSED for severe dementia?
Research shows that music therapy can help improve mood, reduce agitation, and enhance quality of life in people with dementia. Personalized music interventions have been found to reduce the need for medications and improve cognitive and emotional functions, especially in those with mild to moderate dementia.12345
Is music therapy safe for people with dementia?
How is the treatment AMUSED different from other treatments for severe dementia?
Research Team
Alaine E Reschke-Hernandez, PhD
Principal Investigator
University of Kentucky
Eligibility Criteria
This trial is for older adults with severe dementia living in care facilities. They should be able to attend small group sessions and participate in activities. There are no specific inclusion or exclusion criteria provided, but typically participants must meet certain health conditions and not have factors that would prevent them from fully participating.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline
Baseline measures are taken before the intervention begins
Treatment
Participants receive either music therapy or reading sessions twice a week for 12 weeks
Follow-up
Participants are monitored for behavioral symptoms, cognition, and speech after treatment
Treatment Details
Interventions
- AMUSED (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Alaine E Hernandez, PhD
Lead Sponsor
National Institute on Aging (NIA)
Collaborator
Dr. Richard J. Hodes
National Institute on Aging (NIA)
Chief Executive Officer since 1993
MD from Harvard Medical School
Dr. Marie Bernard
National Institute on Aging (NIA)
Chief Medical Officer
MD from Harvard Medical School